Dose of Adrenaline and dopamine in bradycardia
bradycardia management epinephrine dopamine
| Parameter | Detail |
|---|---|
| Indication | Symptomatic bradycardia unresponsive to atropine; cardiogenic shock with bradycardia |
| Preparation | 1 mg in 500 mL normal saline (concentration: 2 mcg/mL) |
| Starting dose | 2 mcg/min IV infusion |
| Titration | Escalate as needed at 3-5 minute intervals |
| Range | 2-10 mcg/min |
| Mechanism | Alpha + Beta adrenergic effects: increases HR, BP, CO |
"For IV infusion in patients with cardiogenic shock or symptomatic bradycardia, the dose is 1 milligram in 500 mL of normal saline beginning at 2 to 10 micrograms/min and escalating as needed at 3- to 5-minute intervals." - Tintinalli's Emergency Medicine
| Parameter | Detail |
|---|---|
| Indication | Symptomatic bradycardia, especially if hypotension co-exists |
| Starting dose | 2-5 mcg/kg/min IV |
| Usual range | 2-20 mcg/kg/min, titrated by 5-10 mcg/kg/min increments |
| Maximum dose | Up to 50 mcg/kg/min (some sources 20-50 mcg/kg/min) |
| Mechanism (dose-dependent): | |
| - Low dose (2-5 mcg/kg/min) | Dopaminergic + mild beta-1: increases HR and inotropy |
| - Medium dose (5-10 mcg/kg/min) | Beta-1 dominant: increases HR, BP, CO |
| - High dose (>10-15 mcg/kg/min) | Alpha dominant: vasoconstriction, decreases renal perfusion |
"Dopamine is a catecholamine with both alpha- and beta-adrenergic actions and can be titrated to target heart rate or vasoconstriction more selectively. At lower doses, dopamine has a more selective effect on inotropy and heart rate; at higher doses (>10 mcg/kg/min), it also has vasoconstrictive effects." - Miller's Anesthesia
| Feature | Epinephrine | Dopamine |
|---|---|---|
| Dose form in bradycardia | 2-10 mcg/min infusion | 2-20 mcg/kg/min infusion |
| Weight-based dosing? | No (fixed mcg/min) | Yes (mcg/kg/min) |
| Preferred if hypotension present | Yes | Yes |
| Preferred if low risk of arrhythmia | Either | Dopamine preferred |
| Arrhythmia risk | Higher | Lower at low doses |
bradycardia algorithm according to ACLS
ACLS bradycardia algorithm 2020 AHA steps

| Sign of Instability |
|---|
| Hypotension |
| Acutely altered mental status |
| Signs of shock |
| Ischemic chest discomfort |
| Acute heart failure |
| Dose | |
|---|---|
| First dose | 1 mg IV bolus |
| Repeat | Every 3-5 minutes |
| Maximum total dose | 3 mg |
Key 2020 update: Dose increased from 0.5 mg to 1 mg per dose to improve efficacy and avoid paradoxical bradycardia (doses < 0.5 mg can cause paradoxical bradycardia).
| Option | Drug / Intervention | Dose |
|---|---|---|
| A | Transcutaneous Pacing (TCP) | Rate typically 60-80/min; use sedation |
| B | Dopamine IV infusion | 5-20 mcg/kg/min - titrate; taper slowly |
| C | Epinephrine IV infusion | 2-10 mcg/min - titrate to response |
| Scenario | Action |
|---|---|
| Mobitz II / complete heart block | Skip atropine - go directly to TCP + pacing preparation |
| Post-cardiac transplant | Atropine ineffective - use isoproterenol 2-10 mcg/min or pace |
| Suspected drug toxicity (BB, CCB) | Treat the cause (glucagon, calcium, lipid emulsion) |
| Reversible cause found | Treat the cause first |
| Drug | Dose |
|---|---|
| Atropine | 1 mg IV bolus, repeat q3-5 min, max 3 mg |
| Dopamine | 5-20 mcg/kg/min IV infusion |
| Epinephrine | 2-10 mcg/min IV infusion |